NCT03368495View on ClinicalTrials.gov

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

PHASE4CompletedINTERVENTIONAL
Enrollment

851

Participants

Timeline

Start Date

November 23, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Vaccine Response Impaired
Interventions
BIOLOGICAL

Co-administration of MMR/YF

Both MMR \& yellow fever vaccines administered on Day 0.

BIOLOGICAL

MMR followed by YF

MMR vaccine administered on Day 0 and yellow fever vaccine administered on Day 28.

BIOLOGICAL

YF followed by MMR

Yellow fever vaccine administered on Day 0 and MMR vaccine administered on Day 28.

Trial Locations (4)

Unknown

SAMIC Eldorado Hospital, Eldorado

SAMIC Obera Hospital, Oberá

Favoloro Hospital, Posadas

IPS Hospital, Posadas

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Ministry of Public Health, Argentina

OTHER_GOV

lead

Alba Maria Ropero

OTHER

NCT03368495 - Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines | Biotech Hunter | Biotech Hunter